In this exclusive video, Enrique Alvarez, from the University of Colorado School of Medicine, offered perspective on data from the DISCOMS study that was recently published in Lancet Neurology, and addressed some of the challenges when deciding whether patients with MS should discontinue disease-modifying therapy (DMT) as they get older.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045